Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 1
1964 3
1965 1
1968 3
1969 2
1970 2
1971 3
1972 5
1973 3
1975 3
1976 3
1978 8
1979 4
1980 5
1981 4
1982 7
1983 3
1984 2
1985 7
1986 4
1987 13
1989 6
1990 4
1991 3
1992 7
1993 5
1994 6
1995 6
1996 2
1997 12
1998 3
1999 13
2000 2
2001 14
2002 11
2003 12
2004 13
2005 12
2006 25
2007 11
2008 19
2009 11
2010 8
2011 11
2012 11
2013 15
2014 16
2015 4
2016 11
2017 5
2018 10
2019 6
2020 8
2021 6
2022 10
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

400 results

Results by year

Filters applied: . Clear all
Page 1
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial.
Agarwal N, Azad AA, Carles J, Fay AP, Matsubara N, Heinrich D, Szczylik C, De Giorgi U, Young Joung J, Fong PCC, Voog E, Jones RJ, Shore ND, Dunshee C, Zschäbitz S, Oldenburg J, Lin X, Healy CG, Di Santo N, Zohren F, Fizazi K. Agarwal N, et al. Among authors: di santo n. Lancet. 2023 Jul 22;402(10398):291-303. doi: 10.1016/S0140-6736(23)01055-3. Epub 2023 Jun 4. Lancet. 2023. PMID: 37285865 Clinical Trial.
First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial.
Fizazi K, Azad AA, Matsubara N, Carles J, Fay AP, De Giorgi U, Joung JY, Fong PCC, Voog E, Jones RJ, Shore ND, Dunshee C, Zschäbitz S, Oldenburg J, Ye D, Lin X, Healy CG, Di Santo N, Laird AD, Zohren F, Agarwal N. Fizazi K, et al. Among authors: di santo n. Nat Med. 2024 Jan;30(1):257-264. doi: 10.1038/s41591-023-02704-x. Epub 2023 Dec 4. Nat Med. 2024. PMID: 38049622 Free PMC article. Clinical Trial.
Nephrotic edema.
De Santo NG, Pollastro RM, Saviano C, Pascale C, Di Stasio V, Chiricone D, Cirillo E, Molino D, Stellato D, Frangiosa A, Favazzi P, Capodicasa L, Bellini L, Anastasio P, Perna A, Sepe J, Cirillo M. De Santo NG, et al. Semin Nephrol. 2001 May;21(3):262-8. doi: 10.1053/snep.2001.21654. Semin Nephrol. 2001. PMID: 11320491 Review.
Survival is not enough.
De Santo NG, Perna A, El Matri A, De Santo RM, Cirillo M. De Santo NG, et al. J Ren Nutr. 2012 Jan;22(1):211-9. doi: 10.1053/j.jrn.2011.10.010. J Ren Nutr. 2012. PMID: 22200445 Review.
The Giordano-Giovannetti diet.
Di Iorio B, De Santo NG, Anastasio P, Perna A, Pollastro MR, Di Micco L, Cirillo M. Di Iorio B, et al. Among authors: de santo ng. J Nephrol. 2013 Dec 23;26(Suppl. 22):143-152. doi: 10.5301/jn.5000367. Online ahead of print. J Nephrol. 2013. PMID: 24375359 No abstract available.
Aquaporins, vasopressin, and aging: current perspectives.
Tamma G, Goswami N, Reichmuth J, De Santo NG, Valenti G. Tamma G, et al. Among authors: de santo ng. Endocrinology. 2015 Mar;156(3):777-88. doi: 10.1210/en.2014-1812. Epub 2014 Dec 16. Endocrinology. 2015. PMID: 25514088 Review.
On the usefulness of the history of nephrology.
Eknoyan G, Rutkowski B, Bellinghieri G, Massry S, Muszytowski M, De Santo NG. Eknoyan G, et al. Among authors: de santo ng. J Nephrol. 2011 May-Jun;24 Suppl 17:S1-3. doi: 10.5301/JN.2011.6489. J Nephrol. 2011. PMID: 21614773 No abstract available.
Luciano Armanni.
De Santo NG, Lamendola MG. De Santo NG, et al. Am J Nephrol. 1994;14(4-6):448-51. doi: 10.1159/000168763. Am J Nephrol. 1994. PMID: 7847484
Malaria as a Papal Disease.
Bisaccia C, De Santo LS, De Santo NG. Bisaccia C, et al. Among authors: de santo ng. Exp Clin Transplant. 2023 Jun;21(Suppl 2):28-32. doi: 10.6002/ect.IAHNCongress.07. Exp Clin Transplant. 2023. PMID: 37496339 Free article.
400 results